One mechanism that has emerged to link infection-stimulated inflammation with altered thrombotic potential of the blood and atherogenic processes is that infection increases production of activated cell membrane-derived pro-inflammatory and procoagulant microvesicles (MV) from invading microbes and host cells which then activate other host cellular and soluble components of the cardiovascular system (10) (11) (12) (13) (14) (15) .